ROCKWELL MEDICAL INC (RMTI) Forecast, Price Target & Analyst Ratings

NASDAQ:RMTI • US7743743004

0.8994 USD
0 (-0.12%)
At close: Mar 3, 2026
0.9498 USD
+0.05 (+5.6%)
After Hours: 3/3/2026, 8:00:02 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ROCKWELL MEDICAL INC (RMTI).

Forecast Snapshot

Consensus Price Target

Price Target
$3.83
+ 325.28% Upside

Next Earnings Forecast

Earnings Estimate
Release DateMar 26, 2026
PeriodQ4 / 2025
EPS Estimate$0.02
Revenue Estimate18.953M

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.83
Upside
+ 325.28%
From current price of $0.90 to mean target of $3.83, Based on 8 analyst forecasts
Low
$2.53
Median
$3.83
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 analysts have analysed RMTI and the average price target is 3.83 USD. This implies a price increase of 325.28% is expected in the next year compared to the current price of 0.8994.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RMTI Current Analyst RatingRMTI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

RMTI Historical Analyst RatingsRMTI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
RMTI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RMTI.
In the previous month the buy percentage consensus was at a similar level.
RMTI was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-26HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-13HC Wainwright & Co.Maintains Buy -> Buy
2025-03-24HC Wainwright & Co.Maintains Buy -> Buy
2024-12-23HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-25HC Wainwright & Co.Maintains Buy -> Buy
2024-11-14Rodman & RenshawInitiate Buy
2024-09-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-25HC Wainwright & Co.Maintains Buy -> Buy
2023-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-05Maxim GroupInitiate Buy
2023-10-04HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-28HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-07-17HC Wainwright & Co.Maintains Buy -> Buy
2023-05-30HC Wainwright & Co.Maintains Buy -> Buy
2023-05-02HC Wainwright & Co.Reiterate Buy
2023-04-04HC Wainwright & Co.Reiterate Buy
2023-02-13HC Wainwright & Co.Reiterate Buy
2023-02-08HC Wainwright & Co.Maintains Buy
2022-08-30HC Wainwright & Co.Maintains Buy
2022-01-18HC Wainwright & Co.Maintains Buy
2021-09-07HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateMar 26, 2026
PeriodQ4 / 2025
EPS Estimate$0.02
Revenue Estimate18.953M
Revenue Q2Q-23.16%
EPS Q2Q202.00%
Number of Analysts4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
12.29%
EPS (1 Month)
200.00%
EPS (3 Months)
150.00%

Next Earnings Summary

RMTI is expected to report earnings on 3/26/2026. The consensus EPS estimate for the next earnings is 0.02 USD and the consensus revenue estimate is 18.95M USD.
The next earnings revenue estimate has been revised upward by 12.29% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
RMTI revenue by date.RMTI revenue by date.
72.81M
17.57%
83.612M
14.84%
101.489M
21.38%
70.883M
-30.16%
76.656M
8.14%
79.475M
3.68%
N/A
EBITDA
YoY % growth
RMTI ebitda by date.RMTI ebitda by date.
-16.2M
45.40%
-5.226M
67.74%
2.788M
153.35%
1.033M
-62.95%
2.832M
174.15%
3.983M
40.64%
N/A
EBIT
YoY % growth
RMTI ebit by date.RMTI ebit by date.
-16.78M
44.69%
-6.67M
60.25%
608K
109.12%
-3.372M
-654.54%
-1.189M
64.73%
-459K
61.41%
12.75M
2,877.78%
Operating Margin
RMTI operating margin by date.RMTI operating margin by date.
-23.05%-7.98%0.60%-4.76%-1.55%-0.58%N/A
EPS
YoY % growth
RMTI eps by date.RMTI eps by date.
-2.00
29.58%
-0.40
80.00%
-0.02
94.75%
-0.16
-652.86%
-0.06
64.52%
-0.04
27.27%
N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.02
202.00%
-0.02
49.00%
-0.03
38.80%
-0.02
59.20%
-0.02
-200.00%
Revenue
Q2Q % growth
18.953M
-23.16%
18.315M
-3.17%
18.227M
13.42%
18.674M
17.25%
19.343M
2.06%
EBITDA
Q2Q % growth
1.618M
-2.59%
128.52K
115.65%
11.22K
104.54%
98.94K
-82.40%
176.46K
-89.09%
EBIT
Q2Q % growth
1.007M
294.03%
-1.109M
18.48%
-1.185M
12.14%
-1.094M
-0.96%
-1.099M
-209.09%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RMTI Yearly Revenue VS EstimatesRMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
RMTI Yearly EPS VS EstimatesRMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-24.78%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-8.13%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
26.47%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ROCKWELL MEDICAL INC / RMTI Forecast FAQ

What is the average price target for ROCKWELL MEDICAL INC (RMTI) stock?

8 analysts have analysed RMTI and the average price target is 3.83 USD. This implies a price increase of 325.28% is expected in the next year compared to the current price of 0.8994.


When does ROCKWELL MEDICAL INC (RMTI) report earnings?

ROCKWELL MEDICAL INC (RMTI) will report earnings on 2026-03-26, after the market close.


What are the consensus estimates for RMTI stock next earnings?

The consensus EPS estimate for the next earnings of ROCKWELL MEDICAL INC (RMTI) is 0.02 USD and the consensus revenue estimate is 18.95M USD.


What is the expected long term growth rate for RMTI stock?

The expected long term growth rate for ROCKWELL MEDICAL INC (RMTI) is -8.13%.